Supporting a role for the GTPase Rab7 in prostate cancer progression.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 24505328.
- Also identified by DOI 10.1371/journal.pone.0087882 and PMC identifier 3914878.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Invasion and subsequent metastasis is the major cause of death from most cancers including prostate cancer. Herein we report on the potential tumor suppressive properties of Rab7, a GTPase that regulates trafficking of lysosomes. The movement of lysosomes to the cell surface in response to environmental cues increases the secretion of proteinases and cell invasion. We determined that Troglitazone and other members of the Thiazolidinedione family inhibit cell-surface directed lysosome trafficking and cathepsin B secretion through a Rab7-dependent mechanism. Moreover, Rab7 shRNA expressing cells were found to be more invasive in vitro and in vivo. Increased invasiveness was accompanied by elevated expression of the c-Met receptor and prolonged downstream signaling, thereby supporting a role for Rab7 as a mediator of signaling down-regulation. Taken together, these results suggested that Rab7 acts as a negative regulator of prostate tumor growth and invasion, providing further evidence for its potential as a tumor suppressor.
Medical subject headings
- Gene Expression Regulation, Enzymologic
- Gene Expression Regulation, Neoplastic
- Prostatic Neoplasms
- Tumor Suppressor Proteins
- rab GTP-Binding Proteins